Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RECOVERY trial for hospitalized pneumonia
ISRCTN50189673Phase 3Recruiting
- Sponsor
- University of Oxford
- Start
- Mar 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
01
Overview
Phase 3, randomised, open-label trial of dexamethasone, baloxavir marboxil and oseltamivir in Influenza A infection, influenza B, community-acquired pneumonia (CAP) and 3 more (8 arms), sponsored by University of Oxford. Primary endpoints: All-cause mortality at 28 days and Time to discharge alive from hospital. Started Mar 2020; status: recruiting.
02
Drugs
dexamethasonebaloxavir marboxiloseltamivir
03
Conditions
Influenza A infectioninfluenza Bcommunity-acquired pneumonia (CAP)coronavirus disease 2019 (COVID-19)viral pneumonia
Beyond the preview
Go deeper on ISRCTN50189673.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN50189673.